Skip to main content
Log in

Evaluation of99mTc labeled diadenosine tetraphosphate as an atherosclerotic plaque imaging agent in experimental models

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

The potential of99mTc labeled P1, P4-di (adenosine-5’)-tetraphosphate (Ap4A) for imaging experimental atherosclerotic plaques was evaluated in New Zealand white (NZW) rabbits. To label the99mTc to Ap4A, stannous tartrate solution was used.99mTc-Ap4A was purified on a Sephadex G-25 column. The radiochemistry purities of99mTc-Ap4A were 85% to 91%. Biodistribution study revealed99mTc-Ap4A cleared from blood rapidly. Thirty min after99mTc-Ap4A administrated on NZW atherosclerotic rabbits, lesion to blood (target/blood, T/B) ratio was 3.17±1.27, and lesions to normal (target/non-target, T/NT) ratio was 5.23±1.87. Shadows of atherosclerotic plaques were clearly visible on radioautographic film. Aortas with atherosclerotic plaques also could be seen on ex vivo gamma camera images. Atherosclerotic abdominal aortas were clearly visible on in vivo images 15 min to 3 h after99mTc-Ap4A administration.99mTc-labeled Ap4A can be used for rapid noninvasive detection of experimental atherosclerotic plaque.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Guo Y. The Animal Models of Human Disease (Chinese). Beijing: Peolples Health Publication, 1982. 129–134

    Google Scholar 

  2. Grundy S M. Atherosclerosis imaging and the future of lipid management. Circulation, 2004, 110 (23): 3509–3511

    Article  PubMed  Google Scholar 

  3. Rapaport E, Zamecnik P C. Presence of diadenosine 5’, 5"-P1, P4-tetraphosphate (Ap4A) in mammalian cells in levels varying widely with proliferative activity of the tissue: a possible positive “pleiotypic activator”. Proc Natl Acad Sci USA, 1976, 73 (11): 3984–3988

    Article  PubMed  CAS  Google Scholar 

  4. Narula J, Virmani R, Iskandrian A E. Strategic targeting of atherosclerotic lesions. J Nucl Cardiol, 1999, 6: 81–90

    Article  PubMed  CAS  Google Scholar 

  5. Pintor J, Miras-Portugal M T. Diadenosine polyphosphates (APXA) as new neurotransmitters. Drug Dev Res, 1993, 28: 259–262

    Article  CAS  Google Scholar 

  6. Elmaleh D R, Narula J, Babich J Wet al. Rapid noninvasive detection of experimental atherosclerotic lesions with novel99mTc-labeled diadenosine tetraphosphates. Proc Natl Acad Sci U S A, 1998, 95: 691–695

    Article  PubMed  CAS  Google Scholar 

  7. Zhang Y X, Wu Z J, Cao W. Radioiodine labeled SP-4 as an imaging agent for atherosclerotic plaques. Nucl Sci Tech, 2000, 11 (4): 234–239

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Cao Wei, male, born in 1970, Doctor in Charge

This project was supported by a grant from National Natural Sciences Foundation of China (No. 30070310).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wei, C., Yongxue, Z. & Rui, A. Evaluation of99mTc labeled diadenosine tetraphosphate as an atherosclerotic plaque imaging agent in experimental models. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 26, 278–280 (2006). https://doi.org/10.1007/BF02829550

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02829550

Key words

Navigation